Arrowhead Pharmaceuticals, Inc.
ARWR
$79.04
$1.301.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.78B | 914.71M | 917.47M | 898.17M | 1.10B |
| Total Receivables | 15.69M | 218.87M | 6.82M | 9.70M | 2.37M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 21.72M | 16.05M | 10.93M | 23.69M | 23.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 20.15M | 24.76M | 15.42M | 15.36M | 13.78M |
| Total Current Assets | 1.84B | 1.17B | 950.64M | 946.92M | 1.14B |
|
|
|||||
| Total Current Assets | 1.84B | 1.17B | 950.64M | 946.92M | 1.14B |
| Net Property, Plant & Equipment | 417.62M | 421.95M | 426.41M | 425.05M | 429.26M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 6.01M | 6.44M | 6.86M | 7.29M | 7.71M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 187.00K | 1.41M | 1.39M | 1.35M | 1.31M |
| Total Assets | 2.27B | 1.60B | 1.39B | 1.38B | 1.57B |
|
|
|||||
| Total Accounts Payable | 30.75M | 32.94M | 17.67M | 33.05M | 9.98M |
| Total Accrued Expenses | 94.51M | 92.78M | 96.24M | 83.77M | 94.71M |
| Short-term Debt | 10.50M | 10.40M | 10.30M | 7.10M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 47.77M | 47.53M | 47.29M | 47.01M | 71.78M |
| Total Finance Division Other Current Liabilities | 111.69M | 163.78M | 23.99M | 23.60M | 44.07M |
| Total Other Current Liabilities | 111.69M | 163.78M | 23.99M | 23.60M | 44.07M |
| Total Current Liabilities | 295.22M | 347.43M | 195.49M | 194.53M | 220.54M |
|
|
|||||
| Total Current Liabilities | 295.22M | 347.43M | 195.49M | 194.53M | 220.54M |
| Long-Term Debt | 1.23B | 538.11M | 582.28M | 560.59M | 561.20M |
| Short-term Debt | 10.50M | 10.40M | 10.30M | 7.10M | -- |
| Capital Leases | 100.11M | 102.13M | 104.11M | 105.69M | 107.53M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 48.62M | 53.83M | -- | -- | -- |
| Total Liabilities | 1.67B | 1.04B | 881.88M | 860.81M | 889.27M |
|
|
|||||
| Common Stock & APIC | 2.40B | 2.21B | 2.14B | 2.12B | 2.11B |
| Retained Earnings | -1.73B | -1.60B | -1.63B | -1.60B | -1.43B |
| Treasury Stock & Other | -52.45M | -46.49M | -46.75M | 5.36M | 4.39M |
| Total Common Equity | 613.98M | 568.42M | 466.05M | 522.31M | 683.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 613.98M | 568.42M | 466.05M | 522.31M | 683.32M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -15.06M | -5.73M | 37.36M | -2.51M | 904.00K |
| Total Equity | 598.92M | 562.70M | 503.42M | 519.81M | 684.23M |
|
|
|||||